Markus Antonius Kuczyk

Markus Antonius Kuczyk's AcademicInfluence.com Rankings

Medical

#3320

World Rank

#3787

Historical Rank

Urology

#29

World Rank

#30

Historical Rank

medical Degrees

Markus Antonius Kuczyk

Philosophy

#9496

World Rank

#13065

Historical Rank

Logic

#6469

World Rank

#7988

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Markus Antonius Kuczyk Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Markus Antonius Kuczyk's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EAU guidelines on renal cell carcinoma: 2014 update. (2010) (2878)
EAU guidelines on renal cell carcinoma: the 2010 update. (2010) (1326)
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. (2019) (905)
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. (2008) (556)
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. (2011) (516)
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). (2004) (476)
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. (2016) (381)
Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. (1998) (249)
Evaluation of long-term toxicity after chemotherapy for testicular cancer. (1996) (248)
Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients (2004) (212)
MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. (2006) (210)
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. (2008) (191)
[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines]. (2012) (183)
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. (1998) (177)
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma. (2019) (159)
Updated European Association of Urology Guidelines Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer. (2017) (149)
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. (1995) (149)
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor (2015) (133)
Long-term effects on sexual function and fertility after treatment of testicular cancer (1999) (131)
Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features (2001) (129)
Guidelines on Bladder Cancer Muscle-invasive and Metastatic (2008) (122)
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study. (2012) (120)
Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. (2004) (120)
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma. (2017) (112)
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. (2017) (109)
Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections. (2000) (107)
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. (2016) (106)
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. (1995) (106)
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms (2008) (103)
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. (2002) (100)
Novel multi‐peptide vaccination in Hla‐A2+ hormone sensitive patients with biochemical relapse of prostate cancer (2009) (100)
Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer (2010) (99)
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma (1994) (98)
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. (2005) (97)
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours (2005) (93)
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle (1996) (93)
Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. (1997) (89)
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients (2012) (86)
Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. (1997) (83)
Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer (2011) (83)
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. (2016) (77)
Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma (2013) (76)
Image-guided radiofrequency ablation of renal cell carcinoma (2007) (74)
Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? (2011) (73)
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. (1999) (73)
Magnetic Resonance-Guided Percutaneous Radiofrequency Ablation of Renal Cell Carcinomas: A Pilot Clinical Study (2005) (71)
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. (2003) (71)
Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer (2010) (69)
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis (2007) (68)
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma. (2018) (68)
Closing the tract of mini-percutaneous nephrolithotomy with gelatine matrix hemostatic sealant can replace nephrostomy tube placement. (2006) (67)
Laparoscopic sentinel lymph node dissection--a novel technique for the staging of prostate cancer. (2006) (66)
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma. (2014) (66)
Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience (2011) (65)
Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis (2008) (65)
A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in-vitro pressure-measurement and microscopic study. (2007) (61)
Fibronectin 1 protein expression in clear cell renal cell carcinoma. (2012) (60)
p53 overexpression as a prognostic factor for advanced stage bladder cancer. (1995) (60)
The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience (2002) (60)
Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer (2014) (60)
Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer. (2005) (59)
Analysis of Risk Factors for Cisplatin-Induced Ototoxicity in Patients With Testicular Cancer (1998) (59)
Surgery for metachronous solitary liver metastases of renal cell carcinoma. (1997) (57)
Involvement of decreased Galectin‐3 expression in the pathogenesis and progression of prostate cancer (2008) (56)
Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis (2006) (54)
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy. (1998) (54)
External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery (2010) (53)
Management of lower-pole stones of 0.8 to 1.5 cm maximal diameter by the minimally invasive percutaneous approach. (2008) (52)
Patterns of Progression After 68Ga-PSMA-Ligand PET/CT-Guided Radiation Therapy for Recurrent Prostate Cancer. (2019) (51)
Caveolin 1 protein expression in renal cell carcinoma predicts survival (2011) (51)
Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. (2005) (51)
Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014 (2015) (49)
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients (1999) (49)
Expression of Ksp-cadherin during kidney development and in renal cell carcinoma (2005) (49)
Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer? (2003) (48)
The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. (2005) (48)
Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. (1995) (48)
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results (2012) (48)
Adiposity and Age are Statistically Related to Enhanced RASSF1A Tumor Suppressor Gene Promoter Methylation in Normal Autopsy Kidney Tissue (2007) (46)
Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation. (2009) (45)
Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results (2015) (44)
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. (2020) (44)
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer (2005) (44)
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial. (2013) (44)
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization. (1998) (44)
Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer (2014) (44)
Activation of PI3K Is Associated with Reduced Survival in Renal Cell Carcinoma (2008) (44)
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer. (1997) (43)
Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response (2014) (42)
Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions. (2006) (42)
Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis (1996) (42)
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. (2007) (42)
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results. (2010) (42)
Cystectomy – Technical Considerations in Male and Female Patients (2005) (42)
DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies (2014) (41)
Second-line systemic therapy for the treatment of metastatic renal cell cancer (2012) (41)
Followup results of a combination of calcitonin gene-related peptide and prostaglandin E1 in the treatment of erectile dysfunction. (1993) (41)
Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties (2013) (40)
Reply to Santhanam Sundar's letter to the editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18. (2011) (40)
Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival (2008) (40)
The rationale for radical cystectomy as primary therapy for T4 bladder cancer (2007) (39)
SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence (2012) (38)
Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines (2005) (38)
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma (2014) (36)
Expression of E-cadherin in primary prostate cancer: correlation with clinical features. (1998) (36)
European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor-Targeted Therapy. (2016) (36)
68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer (2017) (35)
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer. (2001) (34)
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version? (2011) (34)
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. (1998) (34)
High CRP values predict poor survival in patients with penile cancer (2013) (34)
Minimal-invasive perkutane Nephrolitholapaxie (MIP) (2008) (34)
Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder (2013) (34)
The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti‐angiogenic signaling pathways (2009) (33)
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression (2012) (33)
Effects of various phosphodiesterase‐inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro (1996) (32)
Evaluation of MRI/Ultrasound Fusion-Guided Prostate Biopsy Using Transrectal and Transperineal Approaches (2017) (31)
Effects of phosphodiesterase inhibitors on contraction induced by endothelin-1 of isolated human prostatic tissue. (2009) (31)
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels (2005) (31)
Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients (2006) (30)
Radical cystectomy and orthotopic bladder replacement in females. (2006) (30)
Current aspects of the surgical management of organ‐confined, metastatic, and recurrent renal cell cancer (2005) (30)
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma (2013) (30)
Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy (2004) (30)
Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. (2013) (29)
Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation (2009) (29)
German second-opinion network for testicular cancer: Sealing the leaky pipe between evidence and clinical practice (2014) (29)
Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma. (2012) (29)
Cathepsin D expression in renal cell cancer-clinical implications. (2005) (28)
Intracavernous calcitonin gene-related peptide plus prostaglandin E1: possible alternative to penile implants in selected patients. (1994) (28)
Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. (2006) (28)
Small renal cell carcinomas--how dangerous are they really? Results of a large multicenter study. (2014) (28)
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel. (2020) (28)
Decreased Galectin-8 Is a Strong Marker for Recurrence in Urothelial Carcinoma of the Bladder (2011) (27)
Successful combination of transrectal electroejaculation and intracytoplasmic sperm injection in the treatment of anejaculation. (1996) (27)
International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. (2011) (26)
Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study (2013) (26)
Imaging in Suspected Renal‐Cell Carcinoma: Systematic Review (2019) (26)
Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer. (2008) (26)
Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. (1999) (26)
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size (2014) (25)
Neoadjuvant therapy of renal cell carcinoma: A novel treatment option in the era of targeted therapy? (2012) (25)
Laparoscopic retroperitoneal lymph-node dissection with the waterjet is technically feasible and safe in testis-cancer patient. (2005) (24)
Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4. (2010) (24)
Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool of Renal Fibroblasts (2007) (23)
Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies (2014) (23)
Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma? (2016) (23)
A questionnaire-based outcome analysis of the Stamey bladder neck suspension procedure for the treatment of urinary stress incontinence: the Hannover experience. (1998) (22)
Partial unilateral penile thrombosis: magnetic resonance imaging and management. (1998) (22)
Bladder preserving strategies for muscle-invasive bladder cancer (2008) (22)
Phosphodiesterase inhibitors in clinical urology (2013) (22)
Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer (2013) (22)
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma (2014) (22)
Denovo urothelial carcinoma of the upper and lower urinary tract in kidney — transplant patients with end-stage analgesic nephropathy (2004) (22)
Risk factors for relapse in stage I non‐seminomatous germ‐cell tumors: Preliminary results of the German multicenter trial (1999) (22)
Role of Postchemotherapy Surgery in the Management of Patients With Liver Metastases From Germ Cell Tumors (2005) (22)
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature. (2021) (22)
Analysis of complex protein kinase B signalling pathways in human prostate cancer samples (2008) (22)
Tissue microarrays in clinical urology – Technical considerations (2007) (21)
p16INK4a expression and clinicopathologic parameters in renal cell carcinoma. (2007) (21)
Advances in the Treatment of Testicular Cancer (2012) (21)
Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report (2014) (21)
Systemic and cavernous plasma levels of vasoactive intestinal polypeptide during sexual arousal in healthy males (2002) (21)
The impact of extracorporal circulation on therapy-related mortality and long-term survival of patients with renal cell cancer and intracaval neoplastic extension (2002) (21)
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer (2000) (20)
GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma (2014) (20)
Patterns of relapse as determined by 68Ga-PSMA ligand PET/CT after radical prostatectomy (2017) (20)
Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract. (2011) (20)
Metastatic leydig-cell tumors of the testis - report of 4 cases and review of the literature. (1993) (19)
Exposure of human seminal vesicle tissue to phosphodiesterase (PDE) inhibitors antagonizes the contraction induced by norepinephrine and increases production of cyclic nucleotides. (2010) (19)
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters (2005) (19)
Familial occurrence of Leydig cell tumors: a report of a case in a father and his adult son. (1993) (19)
Metastasis of malignant melanoma in the ureter: Possible algorithms for a therapeutic approach (2009) (19)
Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis (2016) (19)
Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer (2019) (19)
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy (2001) (18)
Size does matter: 1.5 Fr. stone baskets almost double irrigation flow during flexible ureteroscopy compared to 1.9 Fr. stone baskets (2006) (18)
Phosphodiesterase type 5 (PDE5) is co-localized with key proteins of the nitric oxide/cyclic GMP signaling in the human prostate (2013) (18)
Recent strategies for the use of paclitaxel in the treatment of urological malignancies (1998) (18)
No androgen withdrawal syndrome for enzalutamide: a report of disease dynamics in the postchemotherapy setting. (2014) (18)
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)]. (2000) (18)
Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma (2015) (17)
Long-term bowel disorders following radial cystectomy: an underestimated issue? (2014) (17)
DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients. (2018) (17)
Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer. (2011) (16)
New ex vivo organ model for percutaneous renal surgery using a laparoendoscopic training box: the sandwich model (2014) (16)
Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM) (2007) (16)
PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation. (2008) (15)
The history of endocrine therapy of benign and malignant diseases of the prostate (2000) (15)
Renal-cell carcinoma with intracaval neoplastic extension: stratification and surgical technique (2004) (15)
Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. (1994) (15)
Detection of p53 gene alteration in renal‐cell cancer by micropreparation techniques of tumor specimens (1995) (15)
Introducing a new sealant applicator for easy, safe, and quick closure of a mini-percutaneous nephrolitholapaxy access tract. (2007) (15)
The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery (2007) (15)
Characterization of the effects of various drugs likely to affect smooth muscle tension on isolated human seminal vesicle tissue. (2010) (15)
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study. (2012) (15)
Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis (2000) (15)
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience (2004) (15)
Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature (2012) (14)
Docetaxel, estramustine and prednisone for hormone-refractory prostate cancer: a single-center experience. (2005) (14)
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy (2016) (14)
Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma (2004) (14)
Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer (2009) (14)
Signatures of Adverse Pathological Features, Androgen Insensitivity and Metastatic Potential in Prostate Cancer. (2015) (13)
Tissue microarrays: applications in urological cancer research (2006) (13)
Use of assisted reproductive techniques for treatment of ejaculatory disorders. (1996) (13)
Acceptance, Prevalence and Indications for Robot-Assisted Laparoscopy - Results of a Survey Among Urologists in Germany, Austria and Switzerland (2015) (13)
Maspin protein expression correlates with tumor progression in non-muscle invasive bladder cancer. (2010) (13)
Orchitis following mumps vaccination in an adult. (1994) (13)
Is there an anti-androgen withdrawal syndrome for enzalutamide? (2014) (13)
An update on the medical therapy of advanced metastatic renal cell carcinoma (2008) (12)
Development of urologic laparoscopy in Germany, Austria, and Switzerland: a survey among urologists (2014) (12)
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group (2002) (12)
ESWL™ in patients suffering from sialolithiasis (1993) (12)
Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma (2010) (12)
Re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60. (2014) (12)
The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts (2020) (12)
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma. (2014) (12)
Expression and distribution of phosphodiesterase isoenzymes in the human male urethra. (2015) (12)
β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer (2019) (12)
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma (2014) (12)
Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis (2013) (12)
Predictive value of decreased p27 Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients (1999) (12)
Rho kinase (ROK)-related proteins in human cavernous arteries: an immunohistochemical and functional approach. (2012) (12)
Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer (2002) (11)
Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy (2020) (11)
High frequency of urothelial cancers in patients with kidney transplantations for end-stage analgesic nephropathy. (1996) (11)
Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 update. (2008) (11)
Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles. (2011) (11)
Cathepsin D Serum Levels Are Not a Valid Serum Marker in Renal Cell Carcinoma (2007) (11)
RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma (2008) (11)
Surgical strategy in late-stage renal cell cancer with intracaval extension. (1998) (10)
Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissue. (2010) (10)
Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human vagina (2014) (10)
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors (2004) (10)
Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer (2013) (10)
Changing concepts in the surgery of renal cell carcinoma (2008) (10)
Endogenous vasoactive peptides and the human vagina--a molecular biology and functional study. (2011) (10)
Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate (2019) (9)
Potential mechanism of action of human growth hormone on isolated human penile erectile tissue. (2010) (9)
Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life (2008) (9)
Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5) (2011) (9)
Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate Cancer (2017) (9)
A randomized trial of risk‐adapted screening for prostate cancer in young men—Results of the first screening round of the PROBASE trial (2022) (9)
Detection of p53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications (2004) (9)
Present state of target therapy for disseminated renal cell carcinoma. (2010) (9)
Evaluating the role of the serotoninergic system in the control of human seminal vesicle smooth muscle-an in vitro approach. (2009) (9)
Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs (2016) (9)
931 IN VITRO FUNCTIONAL RESPONSES OF ISOLATED HUMAN URETHRAL TISSUE TO PHOSPHODIESTERASE (PDE) INHIBITORS (2011) (9)
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer (1999) (8)
Prostate-specific antigen density — a reliable parameter for the detection of prostate cancer? (2004) (8)
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic (2020) (8)
Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. (1999) (8)
Differential expression of urocortin in human testicular germ cells in course of spermatogenesis: role for urocortin in male fertility? (2009) (8)
Effects of arginase inhibitors on the contractile and relaxant responses of isolated human penile erectile tissue (2009) (8)
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]. (1995) (8)
Does Male Sex Influence the Prognosis of Patients with Renal Cancer? (2011) (8)
Laparoscopic Management of the Adult Nonpalpable Testicle (2005) (8)
IS THERE A ROLE OF THE PHOSPHODIESTERASE TYPE 5 (PDE5) IN THE CONTROL OF HUMAN DETRUSOR SMOOTH MUSCLE? A FUNCTIONAL AND MOLECULAR BIOLOGY STUDY (2009) (8)
Intracranial aspergillosis in a non‐immunocompromised patient treated for muscle‐invasive bladder cancer (2004) (8)
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy—Real-World Clinical Impressions and Comparative Review of the Literature (2020) (8)
Granular cell tumour of the urinary bladder (2012) (7)
Transurethral microwave thermotherapy and laser treatment (1997) (7)
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer. (1999) (7)
Is there a significance of histamine in the control of the human male sexual response? (2012) (7)
Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study. (2014) (7)
Urodynamics and transurethral microwave thermotherapy (1998) (7)
Expression of cyclic AMP-dependent protein kinase isoforms in human cavernous arteries: functional significance and relation to phosphodiesterase type 4. (2010) (6)
[Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors]. (2008) (6)
[Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: a possibility for secondary hormonal ablation?]. (2008) (6)
[Implications of TCGA Network Data on 2nd Generation Immunotherapy Concepts Based on PD-L1 and PD-1 Target Structures]. (2015) (6)
Laparoscopic retroperitoneal lymphadenectomy in the management of low‐stage testicular cancer: Technique and results (2005) (6)
Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer (2006) (6)
Radioisotope guided Pelvic lymph node dissection for prostate cancer staging (2005) (6)
Segmental dosimetry, toxicity and long‐term outcome in patients with prostate cancer treated with permanent seed implants (2013) (6)
[Artificial intelligence and neural networks in urology]. (2019) (6)
Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels. (2013) (5)
Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary tract specimens (2013) (5)
Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer (2020) (5)
[Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma]. (2006) (5)
Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue (2020) (5)
DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers (2021) (5)
Steerable antegrade stenting: a new trick of the trade. (2007) (5)
Pharmacologic characterization of human male urethral smooth muscle: an in vitro approach. (2013) (5)
Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients. (2018) (5)
[Pathophysiology and therapy of castration-resistant prostate cancer]. (2013) (5)
[C-reactive protein prior to radical cystectomy: preoperative determination of CRP]. (2014) (5)
Expression and distribution of the transient receptor potential cationic channel A1 (TRPA1) in the human clitoris—comparison to male penile erectile tissue (2017) (5)
Laparoendoscopic partial nephrectomy in single-incision triangulated umbilical surgery (SITUS) technique: Early experience (2015) (5)
THERMOFUSED BLADDER CUFF RESECTION IN NEPHROURETERECTOMY – A NEW APPROACH (2008) (5)
Expression and distribution of cyclic AMP- and cyclic GMP-binding protein kinases in the human vagina- an immunohistochemical study. (2010) (5)
Adherence to a risk‐adapted screening strategy for prostate cancer: First results of the PROBASE trial (2022) (5)
Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesicles (2018) (5)
[Thermotherapy of benign prostatic hyperplasia]. (1995) (5)
504 QUANTIFICATION OF THE THREE RING MODEL OF T. HALD IN 455 BPH PATIENTS (2010) (5)
Age—an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decades (2014) (5)
C-kit-positive multipolar cells in human penile erectile tissue: expression of connexin 43 and relation to trabecular smooth muscle cells. (2010) (5)
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer (2021) (5)
Corrigendum to: "European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer (2008) (4)
Development of a clinical algorithm for treating urethral strictures based on a large retrospective single-center cohort (2016) (4)
[Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies]. (2013) (4)
Rho kinase-related proteins in human vaginal arteries: an immunohistochemical and functional study. (2011) (4)
Rho GDP dissociation inhibitor-β in renal cell carcinoma. (2017) (4)
Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario (2020) (4)
Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer (2021) (4)
Arginase enzymes in the human prostate: expression of arginase isoenzymes and effects of arginase inhibitors on isolated human prostate tissue (2012) (4)
for the recurrence-free and long-term survival of prostate cancer patients (1999) (4)
True Incidence of Gleason 6 Pathology in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) (2016) (4)
The Prognostic Value of DNA Methylation Markers in Renal Cell Cancer: A Systematic Review (2020) (4)
Hemopatch® as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation (2020) (4)
P53 regulated maspin protein expression determines recurrence-free survival of patients with localised prostate cancer (2000) (4)
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) (2018) (4)
Age Distribution for Partial and Radical Nephrectomy: Whose Nephrons are Being Spared? (2013) (4)
Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer. (1999) (4)
[Value of targeted therapies for renal cell cancer]. (2008) (4)
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]. (1998) (3)
V22 LAPAROSCOPIC NERVE SPARING CYSTECTOMY AND ORTHOTOPIC NEOBLADDER IN FEMALE PATIENTS (2007) (3)
[Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study]. (2011) (3)
Effects of endopeptidase inhibition on the contraction-relaxation response of isolated human vaginal tissue. (2013) (3)
Clinical and Microbiological Effects of an Antimicrobial Stewardship Program in Urology—A Single Center Before-After Study (2022) (3)
1018 The role of diabetes mellitus and obesity in localized and metastatic RCC (2012) (3)
Novel therapeutic options for second-line therapy in metastatic renal cell carcinoma. (2016) (3)
STIMULATION OF CYCLIC NUCLEOTIDE PRODUCTION ENHANCES THE RELAXATION INDUCED BY PHOSPHODIESTERASE (PDE) INHIBITORS OF ISOLATED HUMAN PROSTATE TISSUE (2009) (3)
[In vitro effects of a novel class of nitric oxide donating compounds on isolated human urinary bladder]. (2009) (3)
[Secondary hormonal ablation in hormone-independent prostate cancer]. (2009) (3)
[Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis]. (1996) (3)
779The use of FloSealo® to close the track of the Mini-PCNL shortens the hospital stay (2005) (3)
No growth-stimulation of heterotransplanted human testicular cancer cell-lines by recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf). (1993) (3)
Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma (2012) (3)
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer (2019) (3)
[Castration resistant prostate cancer 2015]. (2015) (3)
[Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results]. (2005) (3)
Single-Incision Pyeloplasty—As Feasible As Laparoscopic Pyeloplasty? Results of the Initial Nine Cases (2013) (3)
Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancer (2004) (3)
Development of a clinical algorithm for treating urethral strictures based on a large retrospective single-center cohort. (2016) (3)
Renal Cell Carcinoma EAU Guidelines on (2016) (3)
Bilateral metachronous testicular germ cell tumors occurring in two non-twin brothers. Case report and review of the literature. (1995) (3)
Beta-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer (2019) (3)
115 ANATOMICAL DISTRIBUTION OF PROSTATIC PERIPHERAL NERVE TISSUE -A NOTEABLE PORTION LOCATED ON THE DORSAL SURFACE OF THE APEX (2007) (3)
Testosterone levels in metastatic castration-resistant prostate cancer (mCRPC). (2015) (2)
DNA methylation signature for the assessment of metastatic risk in primary renal cell cancer. (2017) (2)
738 FIBRONECTIN 1 MRNA EXPRESSION CORRELATES WITH RISK OF RECURRENCE IN RENAL CELL CANCER (2011) (2)
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications. (1995) (2)
DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma. (2019) (2)
[Metastatic adult teratoma of the testis. Possibilities of chemotherapy and surgical treatment]. (1994) (2)
329 Expression of the transient receptor potential cationic channel A1 (TRPA1) in the human seminal vesicles – an immunohistochemical and molecular biology study (2013) (2)
[Visual diagnosis while performing transurethral resection of bladder tumors: power or myth?]. (2014) (2)
Heterogeneous p27Kip1 Expression within Primary Renal Cell Cancers, Their Invasive Margins and Peritumoral Renal Parenchyma Correlation with Pathological and Prognostic Features (2007) (2)
549 PHOSPHODIESTERASE TYPE 5 IS CO-LOCALIZED WITH KEY PROTEINS OF THE NITRIC OXIDE/CYCLIC GMP SIGNALING IN THE HUMAN PROSTATE (2011) (2)
[Transurethral en bloc resection of non-muscle invasive bladder cancer. What is the state of the art?]. (2012) (2)
Prediction of Perioperative Death Following Surgery for Renal Cell Carcinoma with Vein Involvement: A Retrospective Study (2015) (2)
Comparison of PD-L1 Scores in Primary Kidney Tumors Versus Accompanying Venous Tumor Thrombi: Retrospective, Comparative, Monocentric Study in Treatment-Naive Patients (2021) (2)
[Efficacy of multikinase inhibitors in the treatment of advanced renal cell cancer. A snapshot]. (2007) (2)
[Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer]. (2003) (2)
[Influence of obesity on urological malignancies]. (2013) (2)
PS-04-010 Expression and distribution of carboanhydrase (CA) in human penile erectile tissue (2016) (2)
Critical Considerations regarding Laparoscopic Nephroureterectomy for the Treatment of Upper Urinary Tract Carcinoma (2007) (2)
Chemotherapy in Locally Advanced and Metastatic Bladder Cancer (2004) (2)
The need for microdissectional tumor cell preparation during the molecular genetic analysis of prostate cancer (1999) (2)
DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma (2021) (2)
[Molecular pathogenesis and prognostic factors in testicular tumor]. (1998) (2)
383 Hyaluronic Acid and Hyal1 Hyaluronidase: Prognostic Markers for Bladder Cancer (2007) (2)
Clinical outcome of renal cell cancer patients subjected to the simultaneous removal of the primary tumour and an intracaval thrombosis. (2006) (2)
[Partial Nephrectomy in cT1 Renal Tumours: Conventional Laparoscopic Partial Nephrectomy Compared with LESS Partial Nephrectomy in SITUS Technique]. (2015) (1)
Analysis of fertility in patients with stage 1 non-seminomatous germ-cell tumours (NSGCT). The German prospective multicenter trial (2003) (1)
Special Edition EAU-ICUD - Review - Kidney Cancer International Consultation on Urologic Diseases and the European Association of Urology International Consultation on Locally Advanced Renal Cell Carcinoma (2011) (1)
THE COMMON SPARED NEUROVASCULAR BUNDLE MIGHT NOT BE SUFFICIENT FOR ALL TYPES OF NERVE DISTRIBUTIONS IN A NERVE SPARING RADICAL PROSTATECTOMY (2006) (1)
384: Prognostic Implications of Epidermal Growth Factor Receptor Expression in Renal Cell Cancer (2006) (1)
EXPRESSION OF PHOSPHODIESTERASE (PDE) ISOENZYMES IN THE HUMAN SEMINAL VESICLE (SV) AND EFFECTS OF PDE INHIBITORS ON THE CONTRACTILE RESPONSES OF ISOLATED HUMAN SEMINAL VESICLE SMOOTH MUSCLE (2008) (1)
Immunohistochemical detection of cathepsin-d expression in prostate-cancer. (1994) (1)
222 EXPRESSION AND DISTRIBUTION OF PHOSPHODIESTERASE (PDE) ISOENZYMES IN THE HUMAN URETHRA (2011) (1)
738 Stimulation of the cyclic AMP/cyclic GMP signalling enhances the relaxation exerted by phosphodiesterase (PDE) inhibitors of isolated human detrusor smooth muscle (2012) (1)
409Evaluation of the effectiveness of the combination of two anticholinergic drugs to treat severe cases of neurogenic bladder (2005) (1)
CpG-island methylation of GATA-family members GATA3 and GATA5 in renal cell carcinoma and association with clinicopathological parameters and progression-free survival. (2012) (1)
[Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]. (1996) (1)
Five years into the national second-opinion project of the German Testicular Cancer Group (GCTSG): Impact on guideline implementation and the quality of care for testicular cancer patients. (2012) (1)
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients (2012) (1)
Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes (2022) (1)
Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients (2004) (1)
Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer (2013) (1)
MANAGEMENT OF LOWER POLE STONES OF 0.8 – 1.5CM MAXIMAL DIAMETER BY MINIMAL INVASIVE PERCUTANEOUS APPROACH (2008) (1)
Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer (2022) (1)
[Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer]. (2011) (1)
ACTIVATION COMBINED BIOMARKERS PI3K AND P-AKT IS ASSOCIATED WITH REDUCED SURVIVAL IN RENAL CELL CARCINOMA (2006) (1)
Localized renal-cell carcinoma: detection of abnormal cells in peritumoral tissue (1995) (1)
[Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?]. (2015) (1)
MP11-20 THE PREDICTIVE ACCURACY BETWEEN CLINICAL STAGING AND PATHOLOGICAL STAGING IN PATIENTS WITH PRIMARY URETHRAL CARCINOMA (2019) (1)
Endopeptidase inhibition attenuates the contraction induced by big endothelin‐1 of isolated human penile erectile tissue (2018) (1)
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma (2013) (1)
Massive Urogenitalblutung (2016) (1)
626 SURGICAL OUTCOME OF RADICAL PROSTATECTOMY AND HOSPITALIZATION TIME DEPEND ON THE NUMBER OF PERFORMED CASES (2007) (1)
1405 EVALUATING THE SIGNIFICANCE OF THE CYCLIC AMP-MEDIATED SIGNALLING IN THE CONTROL OF SMOOTH MUSCLE OF THE HUMAN PROSTATE – A FUNCTIONAL AND BIOCHEMICAL STUDY (2010) (1)
Molecular pathogenesis and molecular prognosis factors of the testicular tumor (1998) (1)
361: Serum Levels of Angiogenin and Vascular Endothelial Growth Factor (VEGF) Predict Metastatic Disease in Renal Cell Cancer Patients (2005) (1)
RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer (2020) (1)
275 GATA5 PROMOTER METHYLATION IS ASSOCIATED WITH METASTASIS AND PROGRESSION FREE SURVIVAL IN RENAL CELL CANCER PATIENTS (2011) (1)
High CRP values predict poor survival in patients with penile cancer (2013) (1)
[Influence of ureter stenting before ureterorenoscopic treatment of ureteral calculi]. (2014) (1)
The German risk-adapted Prostate Cancer Screening Trial (PROBASE): First results after recruitment of 30.000 men (2018) (1)
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment (2022) (1)
Course of transforming growth factor ß1 in the systemic and cavernous blood of healthy males through different penile conditions (2018) (1)
The Prognostic Role of Alterations of the p53 Tumor Suppressor Gene in Superficial and Advanced Stage Bladder Cancer (1995) (1)
23 The German risk-adapted PCA Screening Trial (PROBASE) – first results (2015) (1)
Erratum to Evaluating the Role of the Serotoninergic System in the Control of Human Seminal Vesicle Smooth Muscle An In Vitro Approach [The Journal of Sexual Medicine, (2009), 6, 2672 9) (2010) (1)
656 Improved porcine ex-vivo organ model for percutaneous renal surgery (sandwich-model) using a laparoscopy-training-box (SITUS Box) (2013) (1)
Effects of endopeptidase inhibition on the relaxation response of isolated human penile erectile tissue to vasoactive peptides (2016) (1)
[The interdisciplinary approach to improve treatment quality of prostate cancer. Optimized nerve sparing in radical prostatectomy]. (2007) (1)
Loss of maspin expression in prostate cancer induced by a P53- and HER-2- pathway/overexpression profiling by whole-mount derived tissue microarrays (2003) (1)
Impact of Surgical Experience Before Robot-assisted Partial Nephrectomy on Surgical Outcomes: A Multicenter Analysis of 2500 Patients (2022) (1)
Screening for prostatic cancer: the case for. (1993) (1)
[Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems]. (1995) (1)
384: BFGF Expression in the Invasion Front of the Tumor Reflects the Aggressiveness of Renal Cell Cancer (2005) (1)
DECREASED P27KIP PROTEIN EXPRESSION AS DETERMINED BY TISSUE MICROARRAY ANALYSIS (TMA) PREDICTS THE CLINICAL PROGNOSIS OF RENAL CELL CANCER PATIENTS (2006) (1)
Is β‐endorphin significant in the control of the male sexual response? (2018) (1)
756 SINGLE INCISION TRIANGULATED UMBILICAL SURGERY (SITUS) (2010) (1)
PS-07-001 Prevalence of erectile dysfunction in 45-year old German men in association with risk factors and comorbidities-results of the German male sex-study (2017) (1)
Fast Implantation of an Artificial Urethral Sphincter Through a Peno-scrotal Approach (2007) (1)
305 Expression and Distribution of Key Proteins of the Endocannabinoid System (ECS) in the Human Seminal Vesicles (2018) (1)
Bladder-sparing treatment modalities in the management of invasive bladder cancer (2005) (1)
Clinical implications of the p53 tumor-suppressor gene. (1994) (1)
PTEN-INDEPENDENT ACTIVATION OF THE PKB/AKT PATHWAY IN RENAL CELL CANCER AND INACTIVATION OF P27KIP BY PHOSPHORYLATION AT T157 (2006) (1)
198 Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma (2013) (1)
533 FREQUENT INACTIVATION OF THE PAKT PATHWAY GENES IN NONSEMINOMATOUS GERM CELL TUMORS (2007) (1)
1054 PHARMACOLOGICAL CHARACTERIZATION OF HUMAN MALE URETHRAL SMOOTH MUSCLE: AN IN VITRO APPROACH (2010) (1)
[Advantages of nerve-sparing pelvic surgery. Animal experiments and clinical results]. (2004) (1)
The need for routine adrenalectomy during the surgical treatment of renal cell cancer - the Hannover experience (2002) (1)
Arginase enzymes in the human prostate: A molecular biological and immunohistochemical approach (2019) (1)
Assessment of bowel disorders following radial cystectomy and urinary diversion for muscle-invasive transitional cell carcinoma of the bladder. (2014) (1)
131 DISTRIBUTION OF EXCISED PERIPHERAL NERVE TISSUE ON RADICAL PROSTATECTOMY SPECIMEN'S NERVE SPARING ASPECT (2007) (1)
V40 Laser en bloc resection of bladder tumors: A European multi-center study to evaluate safety, efficacy and outcome (2015) (1)
890: Hyaluronic Acid and HYAL1 Hyaluronidase: Predictors of Bladder Cancer Prognosis (2007) (1)
[Induratio penis plastica and the capability of vaginal penetration in the context of forensic evaluation]. (2014) (0)
Limitations of tissue microarrays in the evaluation of bcl-2 and P53 expression in whole mount derived prostate tissues (2003) (0)
997: Correlation between the Tumor Size and the Biological Aggressiveness of Renal Cell Cancers Classified as T1 Disease (2005) (0)
MP43-01 CYCLIC AMP- AND CYCLIC GMP-BINDING PROTEIN KINASE ENZYMES IN THE HUMAN VAGINA: BIOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDIES (2014) (0)
Treatment of renal cancer in the elderly >75 years (2018) (0)
Cystectomy in the female (2008) (0)
Subject Index Vol. 80, 2008 (2008) (0)
HP-4-5 Effect of Sexual Behavior on Prostate-Specific Antigen Levels in Middle-Aged Men Screened for Prostate Cancer: Results From the Probase Trial (2020) (0)
PD27-02 99mTC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS (2023) (0)
Revisions Title : Caveolin 1 protein expression in renal cell carcinoma predicts survival Version : 1 Date : 8 August 2011 (2011) (0)
CpG-island methylation of GATA-family members GATA3 and GATA5 in renal cell carcinoma and association with clinicopathological parameters and progression-free survival. (2012) (0)
Revisions Title : Caveolin 1 protein expression in renal cell carcinoma predicts survival Version : 1 Date : 8 August 2011 (2011) (0)
Correspondence (letter to the editor): Absence of Desire (2010) (0)
Identification of the biological aggressiveness of renal cell cancer by a “multiparameter” model (2002) (0)
Is superficial bladder cancer mococlonal or polyclonal in origin (2003) (0)
V74 Laparoendoscopic single incision triangulated umbilical surgery (SITUS) for partial nephrectomy: Early experience in the first 13 patients (2015) (0)
416 OBESITY IS ASSOCIATED WITH BETTER PATHOLOGIC FEATURES AND IMPROVED OUTCOME AMONG PATIENTS TREATED SURGICALLY FOR RENAL CELL CARCINOMA (2010) (0)
DECREASED MASPIN PROTEIN CORRELATES WITH TUMOR PROGRESSION AND RECURRENCE IN TRANSITIONAL CELL CARCINOMA (2008) (0)
THE VALUE OF POST-CHEMOTHERAPY SURGERY IN THE MANAGEMENT OF PATIENTS HARBOURING LIVER METATASES FROM GERM CELL TUMOURS (2006) (0)
889Analysis of complex PKB/AKT signalling pathways in human prostate cancer samples (2005) (0)
The recent phosphodiesterase type 5 inhibitors: an update (2012) (0)
IN VITRO FUNCTIONAL RESPONSES OF ISOLATED HUMAN PROSTATE TISSUE TO ARGINASE INHIBITORS (2008) (0)
1603: PTEN - AKT- P27 KIP1 Expression Profile in Benign, Cancerous, Lymph Node Positive and Hormone Refractory Prostate Cancer Tissue (2005) (0)
843 Role of surgery in patients with liver metastases from nonseminomatous germ cell tumors (2003) (0)
CpG island hypermethylation of corticotropin-releasing hormone-binding protein in kidney cancer and association with clinicopathological parameters. (2013) (0)
Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial (2019) (0)
745 Magnet resonance imaging (MRI) is a reliable tool for follow up of extracorporeal shock wave therapy (ESWT) of Peyronie's disease (2004) (0)
801: Nerve Fibres on Radical Prostatectomy Specimens -The Sparing of the Common Neurovascular Bundle Might not be Sufficient for All Types of Nerve Distributions (2006) (0)
078 Further Evidence for a Role of Human Growth Hormone (hGH) in the Control of Penile Erection in the Adult Male (2016) (0)
Transurethral water vapor ablation of the prostate with the Rezūm system: Urodynamic findings (2022) (0)
V1915: Laparoscopic Nerve Sparing Cystectomy and Orthotopic Bladder Replacement in Female Patients (2007) (0)
C70 INVESTIGATING THE SIGNIFICANCE OF THE CYCLIC AMP-MEDIATED SIGNALLING IN THE CONTROL OF THE HUMAN PROSTATE: IMMUNOHISTOCHEMICAL AND FUNCTIONAL STUDIES (2012) (0)
P-02-55 Course of Testosterone in the Systemic and Cavernous Blood Through Different Stages of Sexual Arousal in Healthy Males and Patients With Erectile Dysfuntion (2020) (0)
PD18-11 A NEW OUTCOME PREDICTION MODEL FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY BASED ON PREOPERATIVE PARAMETERS (2014) (0)
' s response to reviews Title : RASSF 1 A protein expression and correlation with clinicopathological parameters in renal cell carcinoma (2008) (0)
6 JOHANN PETER FRANK: REVISITING THE FORGOTTEN FOUNDER OF THE MODERN HEALTHCARE SYSTEM (2009) (0)
940 En bloc resection of urothelium carcinoma of the bladder (EBRUC): A European multi-center study to compare safety, efficacy and 12-months recurrence rate of laser and electrical en bloc TURBT (2015) (0)
430 The endocannabinoid system in male reproductive organs: expression and localization of fatty acid amide hydrolase (FAAH) in the seminal vesicles and vas deferens (2018) (0)
380 Analysis of complex PKB/Akt signaling pathways in human prostate cancer samples (2004) (0)
445: Early Onset and Age-Related Accumulation of the RAS Association Domain Family 1A Promoter Methylation in Normal Kidney Tissue Together with Heterogeneous Loss of Expression Indicate a Role in Tumorigenesis of Renal Cell Cancer (2007) (0)
PD33-04 PRIOR SURGICAL EXPERIENCE AND THE IMPACT ON PERIOPERATIVE OUTCOMES IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY: A MULTICENTER ANALYSIS WITH 2,500 PATIENTS (2022) (0)
623 EVALUATING THE SIGNIFICANCE OF ARGINASE ENZYMES IN THE CONTROL OF THE HUMAN PROSTATE: IN VITRO STUDIES (2010) (0)
Altered P27 KIP1 expression predicts long-term survival of patients with renal cell cancer as demonstrated by tissue microarray analysis (2003) (0)
PD18-10 THE TNR-C SCORE QUALIFIES AS A PROGNOSTIC TOOL FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY: RESULTS OF AN EXTERNAL VALIDATION (2014) (0)
C36 Do serotonin re-uptake inhibitors affect directly the smooth muscle of the human seminal vesicle? A functional and molecular biology study (2009) (0)
Courses of Arginine-Vasopressin in the Systemic and Cavernous Blood through Different Stages of Sexual Arousal in Healthy Males and Patients with Erectile Dysfunction (2023) (0)
TISSUE-BASED GENE EXPRESSION FOR PROGNOSIS OF PROSTATE CANCER LOCAL STAGE (2015) (0)
697 DISTRIBUTION OF PHOSPHODIESTERASE (PDE) ISOENZYMES IN THE HUMAN SEMINAL VESICLE - AN IMMUNOHISTOCHEMICAL STUDY (2010) (0)
Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer (2020) (0)
MP57-04 THE GERMAN RISK-ADAPTED PROSTATE CANCER SCREENING TRIAL (PROBASE) – FIRST RESULTS AFTER RECRUITMENT OF 30.000 MEN (2018) (0)
437 CONTRACTION/RELAXATION RESPONSE STUDIES ON HUMAN MALE URETHRAL SMOOTH MUSCLE: AN IN VITRO APPROACH (2010) (0)
Long-term outcome of cytoreductive surgery for recurrent renal cell carcinoma (2002) (0)
186Correlation between the tumour size and the biological aggressiveness of renal cell cancers classified as T1 disease (2005) (0)
Effect of sexual behavior on prostate-specific antigen levels in middle-aged men screened for prostate cancer: Results from the PROBASE trial (2020) (0)
Development of a new outcome-prediction model for patients with urothelial carcinoma of the bladder prior to cystectomy. (2014) (0)
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. (2015) (0)
1955: MRI-Guided Biopsy of the Prostate Continues to be Promising as a Diagnostic Alternative in Patients with Elevated PSA and Prior Negative Trus Biopsies (2007) (0)
432: Treatment of Late Relapse of Non-Seminomatous Testicular Germ Cell Tumors (2005) (0)
MP75-05 EFFECT OF SEXUAL BEHAVIOR ON PROSTATE-SPECIFIC ANTIGEN LEVELS IN MIDDLE-AGED MEN SCREENED FOR PROSTATE CANCER (2020) (0)
E163 Drugs activating cellular potassium channels: A new option to target urolithiasis? An in vivo animal study (2013) (0)
Cross-sectional evaluation of long-term bowel issues after radical cystectomy. (2017) (0)
C49 Expression of phosphodiesterase (PDE) isoenzymes in the human urethra: A molecular biology and Western blot study (2013) (0)
[Is adrenalectomy an indispensable part of nephrectomy? Results of a multivariate statistical analysis]. (2003) (0)
399 IS THERE A NEED TO FURTHER SUBCLASSIFY PT2 RENAL CELL CANCERS AS IMPLEMENTED BY THE REVISED 7TH TNM VERSION (2011) (0)
713 EXPRESSION AND DISTRIBUTION OF KEY ENZYMES OF THE CYCLIC GMP SIGNALING IN THE HUMAN CLITORIS (2010) (0)
494Mitotic catastrophe marker cyclin B1 in renal cell carcinoma correlates with stage, metastasis and survival of patients (2005) (0)
ENDOPEPTIDASE INHIBITION ‐ A POTENTIAL NEW OPTION TO TARGET ERECTILE DYSFUNCTION? AN IN VITRO STUDY: MP43‐13 (2018) (0)
New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer (1999) (0)
945 Karnofsky-index, cardial insufficiency and suspicion of metastatic disease are predictors of early death within 2 month after surgery for advanced renal cell cancer with veneous involvement (2014) (0)
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. (2013) (0)
[Follow-up of urological tumor treatment]. (2015) (0)
A positive digital rectal examination (DRE) does not predict prostate cancer in 45 yr old men - results from the German risk-adapted PCA Screening Trial (PROBASE) (2017) (0)
Are patients with Gleason 6 pathology safe from developing metastatic castration-resistant prostate cancer (mCRPC)? (2015) (0)
RRU_A_291962 139..145 (2021) (0)
391 GATA5 PROMOTER METHYLATION: A POTENTIAL BIOMARKER FOR METASTASIS AND DISEASE PROGRESSION IN KIDNEY CANCER PATIENTS (2011) (0)
354: Involvement of the PKB/AKT Pathway in the Development and Progression of Renal Cell Carcinomas (2005) (0)
500 Re-evaluation of the latest modification of the TNM-classification for T1 renal cell cancer by multivariate statistical analysis (2004) (0)
Sarcopenia as a useful predictor of postoperative complications following radical cystectomy: An assessment of preoperative CT scans. (2017) (0)
446 RADICAL NEPHRECTOMY IS ASSOCIATED WITH DECREASED OVERALL SURVIVAL COMPARED WITH PARTIAL NEPHRECTOMY (2010) (0)
PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both (2021) (0)
Correlation of the clinical frailty scale with long-term survival after radical cystectomy. (2015) (0)
HP-01-003 Expression of genes encoding for endopeptidase enzymes (EnPEs) and peptide binding receptors in the human vagina # Comparison to penile erectile tissue (2019) (0)
Alteration of thep53Tumor Suppressor Gene in Prostate Cancer: Analytical Approaches and Clinical Implications (1998) (0)
Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Absence of desire. (2010) (0)
DECREASED MASPIN PROTEIN CORRELATES WITH TUMOUR PROGRESSION AND RECURRENCE IN TRANSITIONAL CELL CARCINOMA (2008) (0)
C150 INVESTIGATING THE MECHANISMS CONTROLLING HUMAN URETHRAL SMOOTH MUSCULATURE – IS THERE A ROLE OF PHOSPHODIESTERASE (PDE) ISOENZYMES? (2011) (0)
Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesicles (2022) (0)
Bias of available data makes it unreliable to compare outcomes of thermo-ablation versus surgery for the treatment of T1 renal tumours: A systematic review from the European Association of Urology Renal Cell Cancer Guideline Panel (2020) (0)
338 Do small renal cell carcinomas have a higher prevalance of locally advanced growth and distant metastases? A large multicentre study (2013) (0)
C182: Arginase enzymes in the human prostate: Immunohistochemical and functional studies (2014) (0)
Molecular characterization of temsirolimus-induced response in human renal and bladder cancer cell lines. (2012) (0)
452: The Value of Postchemotherapy Surgery in the Management of Patients Harbouring Liver Metatases from Germ Cell Tumors (2006) (0)
Does double J stenting during transurethral resection of a bladder tumor increase the risk for metachronous upper urinary tract urothelial cancer development? (2020) (0)
URETEROSCOPICALLY ASSISTED LAPAROSCOPIC SEGMENTAL URETERECTOMY WITH PSOAS HITCH PROCEDURE (2008) (0)
DNA hypermethylation biomarkers to predict therapy response of antiangiogenic therapy in metastatic renal cell carcinoma patients. (2014) (0)
514 SFRP1 MRNA EXPRESSION IN RENAL CELL CANCER AND ONCOCYTOMA AND ASSOCIATION WITH CLINICOPATHOLOGICAL PARAMETERS (2010) (0)
Regulation of stem cell-like phenotype and response to chemotherapy in bladder cancer by beta-arrestins. (2019) (0)
RASSF 1 A protein expression and correlation with clinicopathological parameters in renal cell carcinoma (2015) (0)
Bürstner O, et al: De novo malignancies following renal transplantation: Experience of a single center. Onkologie 1995;18:32-38. (1995) (0)
1031 ACTIVATION OF MTOR IN RENAL CELL CARCINOMA DUE TO INCREASED PHOSPHORYLATION RATHER THAN PROTEIN OVER EXPRESSION (2009) (0)
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma (2014) (0)
DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers (2021) (0)
888PTEN — AKT — P27 KIPI expression profile in benign, adjacent and prostate cancer tissue (2005) (0)
365: Signaling of the PKB/AKT in Renal Cell Carcinomas (2005) (0)
PHOSPHODIESTERASE TYPE 5 (PDE5) IN THE HUMAN PROSTATE: RELATION TO KEY ENZYMES OF THE NITRIC OXIDE/CYCLIC GMP SIGNALING: MP17‐20 (2017) (0)
503 OBESITY PREDICTS IMPROVED SURVIVAL IN PATIENTS WITH CLEAR CELL KIDNEY CANCER (2010) (0)
Basic and Translational Science Evaluating the Significance of Cyclic Adenosine Monophosphate-mediated Signaling in Human Prostate: A Functional and Biochemical Study (2012) (0)
Contents Vol. 75, 2005 (2005) (0)
Reduced Expression of the Cell Cycle Regulator p27Kip1 within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific Survival. (2006) (0)
New aspects on the treatment and prognosis of penile cancer (2003) (0)
C53 IS THE MALE POST-EJACULATORY REFRACTORY STATE UNDER THE CONTROL OF HISTA MINE AND THE VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)? (2011) (0)
Rho GDP dissociation inhibitor beta ARHGDIB in renal cell cancer. (2015) (0)
C1 INVESTIGATING THE PHARMACOLOGY OF HUMAN URETHRAL SMOOTH MUSCLE: IN VITRO STUDY (2010) (0)
P-01-007 Further evidence for a significance of cyclic AMP signalling in the human prostate - an immunohistochemical approach (2017) (0)
183 IN VITRO FUNCTIONAL RESPONSES OF ISOLATED HUMAN VAGINAL TISSUE TO VASOACTIVE ENDOGENOUS PEPTIDES AND THEIR INTERACTION WITH CYCLIC NUCLEOSIDE MONOPHOSPHATE PATHWAY (2010) (0)
925: Risk-Adapted Treatment is Not Superior to Surgery – A Quality of Life Analysis of the German Prospective Multicenter Trial in Clinical Stage I NSGCT (2004) (0)
[Therapy for recurrent testicular cancer]. (2005) (0)
1131 Acceptance and indication for robot assisted laparoscopy limited to few indications – results of a 2012 survey among urologists in Germany, Austria and Switzerland (2014) (0)
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma (2014) (0)
68Ga-PSMA PET/CT imaging predicting intraprostatic tumor extent prior to radical prostatectomy in patients with prostate cancer. (2016) (0)
Scientific Programme (2015) (0)
MP-09.04: The Role of Vasoactive Peptides in the Control of Human Vaginal Smooth Muscle Tone: A Molecular Biology and Functional Study (2009) (0)
V9 FAST IMPLANTATION OF AN ARTIFICIAL URETHRAL SPHINCTER THROUGH A PENO-SCROTAL APPROACH (2007) (0)
[Inguinal lymphadenectomy in penis carcinoma]. (2009) (0)
P-01-045 Solo-Masturbation of 45-Year-Old Men Depending on Sexual Orientation Identity and Associated Factors: Findings from the German Male Sex-Study (GMS-Study) (2017) (0)
133 Age distribution for partial and radical nephrectomy – who's nephrons are being spared? (2012) (0)
CORRELATION OF P16INK4 EXPRESSION IN RENAL CELL CARCINOMA WITH CLINICOPATHOLOGICAL PARAMETERS (2006) (0)
654: Mitotic Catastrophe Marker Cyclin B1 in Renal Cell Carcinoma Correlates with Stage Metastasis and Survival of Patients (2005) (0)
457 Analysis of oncogenic human papillomaviruses in the male urogenital system and detection of viral DNA in prostate cancer and seminal vesicle specimens (2004) (0)
[Systemic therapy of malignant adrenal tumors]. (2006) (0)
572 DECREASED EXPRESSION OF HYPOXIA-INDUCIBLE FACTOR 1A AND P27KIP1 IN PATIENTS WITH RENAL CELL CANCER (2010) (0)
961 The revised role of urethrotomy in the treatment of urethral stricture disease: Analysis of 961 cases from a single center (2015) (0)
567 ANALYSIS OF SFRP1 RNA EXPRESSION IN RENAL CELL CANCER AND ONCOCYTOMA AND ASSOCIATION WITH CLINICOPATHOLOGICAL PARAMETERS (2010) (0)
243: Syntenin, an Intracellular Adaptor Molecule, Plays an Important Role in Cell Migration, Invasion and Metastasis of Prostate Cancer Cells (2005) (0)
MP26-04 SAFETY, EFFICACY AND 12-MONTHS RECURRENCE RATE OF LASER VS. ELECTRICAL EN BLOC RESECTION OF UROTHELIUM CARCINOMA OF THE BLADDER: RESULTS OF THE EBRUC TRIAL (2015) (0)
199 Prediction of targeted therapy response in metastatic renal cell carcinoma by DNA methylation markers (2014) (0)
060 Endopeptidase Inhibition: A New Option to Influence Penile Smooth Muscle Tone? An in Vitro Approach (2017) (0)
FRII-09 JOHANN PETER FRANK AND THE DAWNING OF THE MODERN HEALTHCARE SYSTEM: LET THERE BE LIGHT! (2014) (0)
[Massive bleeding of the urogenital tract]. (2017) (0)
C12 ENDOGENOUS NEUROPEPTIDES IN THE CONTROL OF MALE ERECTILE FUNCTION: BETA (SS)-ENDORPHIN (2012) (0)
Incidence of syn- and metachronous adrenal metastasis following tumor nephrectomy: A retrospective bicenter analysis. (2012) (0)
Therapy for kidney cell carcinoma with cava thrombus. Importancy of extracorporeal circulation and prognostic value of cranial tumor extension (1999) (0)
C43 Endothelium-derived peptides in the control of penile erection: Is there a role of bradykinin? (2013) (0)
663 EFFECT OF PARATHYROID HORMONE IN ORCHIECTOMIZED RAT: A POSSIBLE ALTERNATIVE FOR TESTOSTERONE IN THERAPY OF OSTEOPOROSIS IN HIGH-RISK LOCALISED PROSTATE CANCER PATIENTS UNDER ADJUVANT OR NEOADJUVANT HORMONAL THERAPY (2010) (0)
Is cortisol an endogenous mediator of erectile dysfunction in the adult male? (2023) (0)
DECREASED PROTEIN LEVELS OF GALECTIN-8 ARE ASSOCIATED WITH TUMOR PROGRESSION IN TRANSITIONAL CELL CARCINOMA (2008) (0)
628 IS THERE A SIGNIFICANCE OF THE CYCLIC AMP-MEDIATED SIGNALLING IN THE CONTROL OF THE HUMAN PROSTATE? A FUNCTIONAL AND BIOCHEMICAL STUDY (2010) (0)
132 IS MULTIPHASE COMPUTED TOMOGRAPHY AN APPROPRIATE TOOL TO DIFFERENTIATE BETWEEN RENAL ONCOCYTOMA AND RENAL CELL CARCINOMA (2009) (0)
845 GEORG PRAETORIUS: THE DAWNING OF MODERN UROLOGY IN HANOVER (2010) (0)
Association of reduced GATA1 mRNA expression with clinicopathology and shortened recurrence-free survival in clear cell renal cell carcinoma. (2014) (0)
702 Correlation of BFGF expression in renal cell cancer with clinical and histopathological features as demonstrated by tissue microarray analysis and measurement of serum levels (2004) (0)
C80 PHOSPHODIESTERASE ENZYMESAND THE MALE EJACULATORY SYSTEM: EXPRESSION OF PDE ISOENZYMES IN THE SEMINAL VESICLES (2010) (0)
Protein kinase enzymes in the human vagina—relation to key mediators of the cyclic AMP and cyclic GMP pathways (2017) (0)
QUANTITATIVE ANALYSIS OF RAS ASSOCIATION FAMILY 1A GENE (RASSF1A) PROMOTER METHYLATION IN RENAL CELL CARCINOMA, PERITUMOURAL AND NORMAL RENAL PARENCHYMA (2006) (0)
An Advanced Method for the Immunohistochemical Detection of Nitric Oxide Synthase (NOS) in the Female Genital Tract. (2021) (0)
C38: Is there a role of human growth hormone in the control of penile erection in the adult male? (2014) (0)
183 Levels of Transforming Growth Factor ß1 (TGF ß1) in the Systemic and Cavernous Blood of Healthy Males during different Penile Conditions (2019) (0)
921 The role of serum estrogene levels for patients with testicular cancer (1995) (0)
CORRELATION OF RAS ASSOCIATION FAMILY 1A GENE EXPRESSION IN RENAL CELL CARCINOMA WITH PATHOLOGICAL PARAMETERS AND SURVIVAL OF PATIENTS (2006) (0)
MP19-02 EXPRESSION AND DISTRIBUTION OF ARGINASE ENZYMES IN THE HUMAN PROSTATE: AN IMMUNOHISTOCHEMICAL APPROACH (2014) (0)
371 CELL-ADHISON GENE EXPRESSION SIGNATURE DISTINGUISH RENAL CELL CANCER FROM ONCOCYTOMAS (2010) (0)
739 Phosphodiesterase isoenzymes in the human urethra: Relation to neuronal nitric oxide synthase-, VIP- and CGRP-containing nerves (2012) (0)
644: Cathepsin D is a Marker for Early Stage Renal Cell Cancer and Predicts the Presence of Distant Metastases (2005) (0)
A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma (2018) (0)
746 PHOSPHODIESTERASE TYPE 1, THE CALCITONIN-GENE RELATED PEPTIDE AND VASOACTIVE INTESTINAL POLYPEPTIDE ARE INVOLVED IN THE CONTROL OF HUMAN VAGINAL ARTERIAL VESSELS (2011) (0)
Management of sporadic renal angiomyolipomas. A systematic review of available evidence to guide recommendations from the EAU RCC Guidelines panel (2020) (0)
EXPRESSION AND DISTRIBUTION OF THE TRANSIENT RECEPTOR POTENTIAL CATIONIC CHANNEL A1 (TRPA1) IN THE HUMAN SEMINAL VESICLES in JOURNAL OF SEXUAL MEDICINE, vol 9, issue , pp 270-270 (2012) (0)
Re‐evaluation of the immunohistochemical distribution of isoforms of nitric oxide synthase in the human prostate: A light and electron microscopical study (2021) (0)
963 DIAGNOSIS, METASTASIS AND RECURRENCE OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER ARE ASSOCIATED WITH EXPRESSION OF HYALURONIC ACID REGULATORS (2010) (0)
Do body mass index (BMI) and body surface area (BSA) influence the outcome of metastatic renal cell carcinoma? (2011) (0)
Cystectomy for Nonmuscle-Invasive Bladder Cancer (2011) (0)
BFGF EXPRESSION IN RENAL CELL CANCER : CORRELATION WITH CLINICAL AND HISTOLOGICAL FEATURES BY TISSUE MICROARRAY ANALYSIS AND MEASUREMENT OF SERUM LEVELS (2006) (0)
277 EPIGENETIC ALTERATION AND GENE SILENCING OF CORTICOTROPIN-RELEASING FACTOR SYSTEM IN HUMAN KIDNEY CANCER: CORRELATION WITH HISTOPATHOLOGICAL PARAMETERS (2011) (0)
293 Oxaliplatin and paclitaxel: A well tolerated and active chemotherapeutic regimen for collecting (bellini) duct carcinoma of the kidney (2004) (0)
36 Cathepsin D is a marker for early stage renal cell cancer and predicts the presence of distant metastases (2005) (0)
209 MRNA EXPRESSION OF FIBRONECTIN 1 CORRELATES WITH RISK OF PROGRESSION IN RENAL CELL CANCER (2010) (0)
Renal Cell Carcinoma GUIDELINES ON RENAL CELL CARCINOMA (2008) (0)
390 THE ROLE OF AKT PATHWAY RELATED PROTEINS AS PREDICTORS OF TUMOR PROGRESSION IN SUPERFICIAL BLADDER CANCER (2007) (0)
647 Overall survival benefit of partial over radical nephrectomy in patients presenting with renal cell carcinoma (2014) (0)
Risk factors for relapse in stage I non-seminomatous germ-cell tumors : Preliminary results of the German multicenter trial : Special Section : UICC Symposium on Testicular Cancer (1999) (0)
A QUESTIONNAIRE - BASED OUTCOME ANALYSIS OF STAMEY BLADDER NECK SUSPENSION PROCEDURE (1999) (0)
107: Analysis of Oncogenic Human Papilloma Viruses in the Male Urogenital System and Detection of Viral DNA in Prostate Cancer and Seminal Vesicle Specimens (2004) (0)
833: Does Differential Expression Analysis of Akt Pathway Proteins in Superficial Bladder Cancer Help to Identify Patients at High Risk for Tumor Progression ? (2006) (0)
495Invade or proliferate? A comparative analysis of expression of cell cycle regulators in invasive margin and primary tumour tissue in renal cell cancer (2005) (0)
MP52-07 EXPRESSION AND DISTRIBUTION OF CANNABINOID RECEPTORS IN THE HUMAN SEMINAL VESICLES (2015) (0)
231: Pten - AKT - P27 KIP1 Expression Profile in Benigne, Adjacent and Prostate Cancer Tissue (2005) (0)
652: Invade or Proliferate? A Comparative Analysis of Expression of Cell Cycle Regulators in Invasive Margin and Primary Tumor Tissue in Renal Cell Cancer (2005) (0)
E91 The effects of potassium channel activators on isolated human ureteral smooth muscle (2013) (0)
MP57-13 SPIDER SILK NERVE RECONSTRUCTION IN ROBOTIC RADICAL PROSTATECTOMY: A FIRST IN MEN ANALYSIS (2022) (0)
C12 Investigating the significance of phosphodiesterase (PDE) isoenzymes in the control of the human detrusor – a functional and molecular biology approach (2009) (0)
4Adrenalectomy is a curative treatment option for renal cell cancer patients with solitary intraadrenal metastatic spread (2005) (0)
220 Multi-center results of computerized transrectal ultrasound (ANNA/C-TRUS) targeted prostate biopsies in 2356 cases (2015) (0)
Expression of Phosphodiesterase (PDE) Isoenzymes in the Human Male and Female Urethra (2021) (0)
395: Decreased P27KIP Protein Expression as Determined by Tissue Microarray Analysis (TMA) Predicts the Clinical Prognosis of Renal Cell Cancer Patients (2006) (0)
Symposium Interdisciplinary Update on Congenital Diaphragmatic Hernia (2007) (0)
Low frequence of alterations at the P27 Kip1 gene locus in localized prostate cancer (2002) (0)
PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL (2019) (0)
1059 SINGLE INCISION PYELOPLASTY (SIP) IN DAILY ROUTINE: FACTS AND FUTURE (2011) (0)
[Interdisciplinary recommendations for the treatment of advanced metastatic renal cell carcinoma]. (2020) (0)
241 Preoperativ serum C-reactive protein: A prognostic marker in patients with upper urinary tract urothelial carcinoma (2013) (0)
1307 OVERALL SURVIVAL BENEFIT FOR PATIENTS PRESENTING WITH RENAL CELL CARCINOMA UNDERGOING NEPHRON SPARING SURGERY COMPARED TO RADICAL NEPHRECTOMY (2013) (0)
V74 Single incision pyeloplasty – results of the initial 22 cases (2013) (0)
611 IS THERE A SIGNIFICANCE OF PHOSPHODIESTERASE (PDE) ISOENZYMES IN THE CONTROL OF THE HUMAN DETRUSOR? AN IMMUNOHISTOCHEMICAL AND FUNCTIONAL STUDY (2009) (0)
Efficacy of abiraterone acetate in the treatment of castration-resistant prostate cancer: Early results from the German compassionate-use program. (2012) (0)
Body composition parameter as risk predictor in metastatic renal cell carcinoma (mRCC)? (2022) (0)
Quantitative comparison of mRNA level of corticotropin- releasing factor peptide family in normal kidney and corresponding clear cell renal cell carcinoma specimens. (2015) (0)
p53 mutant gene expression in paraffin embedded and fresh frozen tissue of different urogenital tumors. (1994) (0)
904 Is the cyclic AMP signaling a pivotal player in the control of prostate smooth muscle? A biochemical and functional approach (2013) (0)
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. (2014) (0)
445 ONCOCYTOMAS DIFFER FROM RENAL CELL CANCER REGARDING AKT SIGNALING PARAMETERS - BIOLOGICAL AND CLINICAL IMPLICATIONS (2007) (0)
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. (2019) (0)
42: Adrenalectomy is a Curative Treatment Option for Renal Cell Cancer Patients with Solitary Intraadrenal Metastatic Spread (2005) (0)
798 INVESTIGATING THE MALE POST-EJACULATORY REFRACTORY PERIOD IS THERE A ROLE OF HISTAMINE AND THE VASOACTIVE INTESTINAL POLYPEPTIDE? (2012) (0)
570Docetaxel, estramustine and prednisone for the treatment of hormone refractory prostate cancer: A single center experience (2005) (0)
88 BENIGN KIDNEY TISSUE AND RENAL CELL CARCINOMA CAN BE DIFFERENTIATED BY CAVEOLIN1 AND ITGA5 GENE EXPRESSION (2010) (0)
The role of diabetes mellitus in localized and metastatic renal cell carcinoma (2011) (0)
29 INVOLVEMENT OF A DIFFERENTIAL SUBCELLULAR LOCALIZATION OF PTEN, (P-)AKTAND P27KIP1 IN THE PROGRESSION OF RENAL CELL CANCER (2007) (0)
1021 ACTIVATION OF THE C-KIT - STEM CELL FACTOR (SCF) SYSTEM IN RENAL TUMORS – CELLULAR SHIFT OF C-KIT AS A CRITERION OF MALIGNANCY (2009) (0)
MRI-GUIDED PROSTATE BIOPSY IN A ROUTINE SETTING: FIRST RESULTS IN INDIVIDUALS WITH ELEVATED PSA LEVELS AND NEGATIVE TRUS-BIOPSY (2006) (0)
Incidence of syn- and metachronous adrenal metastasis following tumor nephrectomy: A retrospective bicenter analysis. (2012) (0)
V45 Thulium:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer (2012) (0)
MP52-17 EXPRESSION AND DISTRIBUTION OF THE TRANSIENT RECEPTOR POTENTIAL CATIONIC CHANNEL A1 (TRPA1) IN HUMAN PENILE ERECTILE TISSUE AND THE SEMINAL VESICLES (2015) (0)
C-reactive protein prior to cystectomy: An external validation of the TNR-C score. (2014) (0)
Molecular characterization of temsirolimus-induced response in human renal and bladder cancer cell lines. (2012) (0)
808 PHOSPHODIESTERASE TYPE 5 (PDE5) IS CO-LOCALIZED WITH KEY MEDIATORS OF THE CYCLIC GMP SIGNALING IN THE HUMAN CLITORIS (2013) (0)
783 Recommendations for 2nd generation immunotherapy concepts based on analysis of B7-H1 expression data from the TCGA Kidney Renal Clear Cell Carcinoma study (2015) (0)
Laser versus electrical en bloc resection of bladder tumors: Results of a European multicenter study (EBRUC). (2015) (0)
Renal Cell Carcinoma Table 1 : The 2009 Tnm staging classification system (2011) (0)
89 The association between family history and prostate-specific antigen from a large group of 45-year old men embarking on prostate cancer screening: Results from the PROBASE trial (2016) (0)
Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS) (2022) (0)
312 Endogenous Vasoactive Peptides in the Control of Penile Erectile Tissue: Is there a Role of Arginine-Vasopressin (AVP)? (2020) (0)
Contents Vol. 80, 2008 (2008) (0)
[Anterior exenteration in the woman]. (2009) (0)
88 Syntenin, an intracellular adaptor molecule, plays an important role in cell migration, invasion and metastasis of prostate cancer cells (2005) (0)
CROSS‐SECTIONAL STUDY EVALUATING LONG‐TERM BOWEL ISSUES IN BLADDER CANCER PATIENTS: DIARRHEA AS A LIMITING FACTOR OF QUALITY OF LIFE AFTER RADICAL CYSTECTOMY: PD57‐11 (2017) (0)
Prediction of therapy failure after VEGF-based first-line treatment of kidney cancer patients by DNA hypermethylation biomarkers. (2013) (0)
Subject Index Vol. 75, 2005 (2005) (0)
895 Cyclic GMP-binding protein kinases are colocalised with isoforms of the cyclic AMP-specific phosphodiesterase type 4 (PDE4) in the human prostate: An immunohistochemical study (2014) (0)
Sarcopenia as a marker for prediction of long-term survival following radical cystectomy. (2016) (0)
747 EFFECTS OF ENDOPEPTIDASE INHIBITION ON THE CONTRACTION-RELAXATION RESPONSE OF ISOLATED HUMAN VAGINAL TISSUE (2011) (0)
Diarrhea as a limiting factor of quality of life after radical cystectomy: Results from a cross-sectional study evaluating long-term bowel issues in bladder cancer patients (2017) (0)
394: Activation Combined Biomarkers PI3K and P-AKT is Associated with Reduced Survival in Renal Cell Carcinoma (2006) (0)
Prognostic Impact of Lymphnode Metastases in Patients with Metastatic Renal Cell Carcinoma (2021) (0)
V8-08 LASER EN BLOC RESECTION OF BLADDER TUMORS: A EUROPEAN MULTI-CENTER STUDY TO EVALUATE SAFETY, EFFICACY AND OUTCOME (2015) (0)
THE ENDOCANNABINOID SYSTEM IN MALE REPRODUCTIVE FUNCTION: EXPRESSION AND LOCALIZATION OF FATTY ACID AMIDE HYDROLASE (FAAH) IN THE SEMINAL VESICLES AND VAS DEFERENS: MP43‐10 (2018) (0)
Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue (2020) (0)
An Electric Cable As A Foreign Body In The Urethra (2005) (0)
Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre (2023) (0)
“Antisurvival” Factor Treatment for Hormone Refractory Prostate Cancer: Secondary Hormonal Ablation Using Somatostatin Analogs (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Markus Antonius Kuczyk?

Markus Antonius Kuczyk is affiliated with the following schools:

University of Indonesia
University of Rostock
Hannover Medical School
University of Tübingen

Markus Antonius Kuczyk's Academic­Influence.com Rankings

Why Is Markus Antonius Kuczyk Influential?

Markus Antonius Kuczyk's Published Works

Published Works

What Schools Are Affiliated With Markus Antonius Kuczyk?

Markus Antonius Kuczyk's AcademicInfluence.com Rankings